CN117126830A - Preparation method of ginsenoside glycosidase - Google Patents
Preparation method of ginsenoside glycosidase Download PDFInfo
- Publication number
- CN117126830A CN117126830A CN202310809585.0A CN202310809585A CN117126830A CN 117126830 A CN117126830 A CN 117126830A CN 202310809585 A CN202310809585 A CN 202310809585A CN 117126830 A CN117126830 A CN 117126830A
- Authority
- CN
- China
- Prior art keywords
- ginsenoside
- saponin
- culture medium
- preparing
- glycosyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930182494 ginsenoside Natural products 0.000 title claims abstract description 58
- 229940089161 ginsenoside Drugs 0.000 title claims abstract description 57
- 102000005744 Glycoside Hydrolases Human genes 0.000 title claims abstract description 30
- 108010031186 Glycoside Hydrolases Proteins 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 229930182490 saponin Natural products 0.000 claims abstract description 55
- 125000003147 glycosyl group Chemical group 0.000 claims abstract description 46
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 38
- 150000007949 saponins Chemical class 0.000 claims abstract description 30
- -1 PPT saponin Chemical class 0.000 claims abstract description 28
- 239000001963 growth medium Substances 0.000 claims abstract description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 17
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims abstract description 15
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims abstract description 15
- 150000002009 diols Chemical class 0.000 claims abstract description 12
- 230000006698 induction Effects 0.000 claims abstract description 12
- 238000012258 culturing Methods 0.000 claims abstract description 11
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 240000006439 Aspergillus oryzae Species 0.000 claims abstract description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims abstract description 5
- 238000011081 inoculation Methods 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 claims description 6
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 claims description 3
- LLPWNQMSUYAGQI-QBQUQATFSA-N Ginsenoside R1 Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)CO2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 LLPWNQMSUYAGQI-QBQUQATFSA-N 0.000 claims description 3
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims description 3
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- YQKCHRBAJSATCG-UHFFFAOYSA-N UNPD30744 Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC(C)(CCC=C(C)C)C2C3C(C4(CCC5C(C)(C)C(OC6C(C(O)C(O)C(CO)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CC3O)C)(C)CC2)O1 YQKCHRBAJSATCG-UHFFFAOYSA-N 0.000 claims description 3
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 3
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 claims description 3
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims description 3
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 claims description 3
- NODILNFGTFIURN-USYOXQFSSA-N ginsenoside Rb3 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-USYOXQFSSA-N 0.000 claims description 3
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 claims description 3
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 claims description 3
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims description 3
- UVBLDLGZDSGCSN-UHFFFAOYSA-N ginsenoside-Rb3 Natural products C1=CC2C3(C)CCC(O)C(C)(C)C3CCC2(C)C2(C)CCC34CCC(C)C(C)C4C21OC3=O UVBLDLGZDSGCSN-UHFFFAOYSA-N 0.000 claims description 3
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 claims description 3
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 claims description 3
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- LLPWNQMSUYAGQI-UHFFFAOYSA-N notoginsenoside r1 Chemical compound C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O LLPWNQMSUYAGQI-UHFFFAOYSA-N 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- 235000017709 saponins Nutrition 0.000 description 47
- 238000006243 chemical reaction Methods 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 16
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 229910052799 carbon Inorganic materials 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 239000012295 chemical reaction liquid Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 8
- 238000001514 detection method Methods 0.000 description 6
- 239000000306 component Substances 0.000 description 5
- 239000007791 liquid phase Substances 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000007974 sodium acetate buffer Substances 0.000 description 3
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000131386 Aspergillus sojae Species 0.000 description 1
- 241001465318 Aspergillus terreus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 125000000328 arabinofuranosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a preparation method of ginsenoside glycosidase, which comprises the steps of preparing a basic culture medium, inoculating strains, culturing, primary induction, secondary induction and extraction; the inoculation strain: the strain used is Aspergillus oryzae. The primary induction: glycerol and PPD saponin are added into the culture medium, and the culture is carried out for 3-4d. The secondary induction: PPT saponin is added into the culture medium, and the culture is carried out for 3-4d. The ginsenoside glycosidase prepared by the invention has no selectivity to ginsenoside aglycone, glycosyl position and glycosyl type, and can hydrolyze diol and triol ginsenoside simultaneously.
Description
Technical Field
The invention relates to ginsenoside glycosidase and a preparation method of the ginsenoside glycosidase.
Background
Natural products human beings obtain huge treasury of functional raw materials, and animal and plant microorganisms are sources of natural products and active ingredients in the natural products. However, the natural structures of the active ingredients are not the most active structures, they often exist in the form of prodrugs, which need to be metabolized in the organism to secondary metabolites before they can be used. For example, ginsenoside, an active ingredient of ginseng, can be classified into dammarane type saponins including two major categories of diols and triols and small amounts of oleanolic acid type saponins according to the aglycone structure. The natural ginsenoside contains 3-4 glycosyl groups (diol saponins comprise Rb1, rb2, rb3, rc and Rd, and triol saponins comprise R1, re and Rg 1), and is only absorbed and utilized after being metabolized into secondary ginsenoside with low glycosyl groups. Therefore, the preparation of low-sugar saponins has become a research hotspot in recent years. The traditional physicochemical method can convert natural saponins to prepare secondary saponins, but the prepared saponins have the advantages of limited types, more byproducts, large environmental pollution, difficult control of the process, large separation difficulty, environmental friendliness, strong specificity and the like, and the bioconversion method becomes the trend of structural modification of ginsenoside.
The ginsenoside glycosidase which is discovered in the past has the characteristics that one enzyme can only recognize one substrate and hydrolyze one glycosidic bond, and the enzyme has high specificity, but has high requirement on the substrate, can complete conversion only by using a single substrate, and has high application cost.
In order to prepare rare ginsenosides at low cost, a series of novel enzymes have been developed by the present team, such as type I ginsenoside having selectivity for aglycone and no selectivity for glycosyl position and glycosyl type, type II ginsenoside having selectivity for aglycone and glycosyl position and no selectivity for glycosyl type, type III ginsenoside having selectivity for aglycone and glycosyl position and no selectivity for glycosyl type, type IV ginsenoside having selectivity for aglycone and glycosyl position and no selectivity for glycosyl type, which hydrolyze different substrates to produce the same product, and thus are more suitable for preparing secondary saponins.
However, these enzymes are selective for aglycones, i.e. during application the enzymes must be prepared separately for the product to be converted, and the diol saponins and triol saponins in the substrate must be separated. If an enzyme is available that is not specific to aglycone, the transformation conditions and costs are further reduced.
Based on the above problems, the present team developed a method for inducing microorganisms to produce novel enzymes having no selectivity for ginsenoside, and for simultaneously converting diol and triol saponins.
Disclosure of Invention
Aiming at the technical problems, the invention provides a preparation method of ginsenoside glycosidase, which aims to achieve the following purposes: a ginsenoside glycosidase is prepared, which has no selectivity to ginsenoside, and can convert diol and triol saponins simultaneously.
In order to achieve the above object, the present invention adopts the following technical scheme:
a preparation method of ginsenoside glycosidase comprises the following steps:
step 1, preparing a basic culture medium
The basic culture medium comprises the following components in percentage by mass: 0.8-1.2% peptone, 0.1-1% glucose, 0.1-0.3% ZnCl 2 The water makes up the balance.
Step 2, inoculating strains
Inoculating strain into the basic culture medium, wherein the strain is Aspergillus oryzae. The inoculation amount is 1-9%.
Step 3, culturing
Culturing at 25-30deg.C under normal pressure, and introducing sterile air with the amount of 0.5-1.5 m/hr; culturing for 3-4d.
Step 4, primary induction
Adding glycerol and PPD saponin (diol ginsenoside) into the culture medium, and culturing for 3-4d.
The addition amount of the glycerol is 0.1-0.2% of the mass of the basic culture medium; the adding amount of the PPD saponin is 0.1-1% of the mass of the basic culture medium, and the PPD saponin is prepared from ginsenoside Rb1, rb2, rb3, rc and Rd according to the following ratio of (0.2-1): (0.2-1): (0.2-1): (0.2-1) and mixing the components.
Step 5, secondary induction
Adding PPT saponin (triol ginsenoside) into the culture medium, and culturing for 3-4d.
The adding amount of the PPT saponin is 0.1-1% of the mass of the basic culture medium, and the PPT saponin is prepared from ginsenoside R1, re and Rg1 according to the following ratio of (0.2-1): (0.2-1) and mixing the components.
Step 6, extracting
After removing the cells by centrifugation, the liquid phase is retained. Adding edible ethanol into the liquid phase, standing for 3 hr, centrifuging or filtering, and collecting precipitate to obtain ginsenoside glycosidase.
The edible ethanol: the ethanol content is 95% (volume fraction), and the addition amount is 3-4 times of the mass of the liquid phase;
removing thallus by centrifugation, adding, centrifuging or filtering, and collecting precipitate to obtain enzyme protein.
The strain adopted by the invention can also be one of aspergillus sojae, aspergillus niger, aspergillus terreus and lactobacillus.
The invention has the following beneficial effects:
(1) The ginsenoside glycosidase prepared by the invention has no selectivity to ginsenoside aglycone, glycosyl position and glycosyl type, and can be used for simultaneously carrying out enzymolysis on diol and triol type ginsenoside; the enzymolysis conversion rate is about 100%.
(2) The ginsenoside glycosidase prepared by the invention is used for enzymolysis of PPD saponin, different intermediate products can be obtained by controlling the reaction time, and when the reaction is carried out for 2 hours, GYP17, CO, CMC1, CMx and Rd are found in the products by sampling and detecting the reaction liquid; when the reaction is carried out for 5 hours, the reaction liquid is sampled and detected to find that GYP75, CY, CMc, CMx, F2, R-Rg3 and S-Rg3 exist in the product; when the reaction is carried out for 24 hours, sampling and detecting the reaction liquid to find CK, R-Rh2 and S-Rh2 in the products; when the reaction was carried out for 48 hours, the reaction product had only two aglycones of R type and S type.
(3) The ginsenoside glycosidase prepared by the invention is used for enzymolysis of PPT saponin, different intermediate products can be obtained by controlling the reaction time, and when the reaction is carried out for 5 hours, the reaction liquid is sampled and detected to find that Rg1, R-Rg2 and S-Rg2 exist in the products; when the reaction is carried out for 24 hours, the reaction liquid is sampled and detected to find F1, R-Rh1 and S-Rh1 in the products; when the reaction was carried out for 48 hours, only two aglycones of R type and S type were present in the reaction product.
Drawings
FIG. 1 is a HPLC chart of PPD saponin before enzymolysis in example 2;
FIG. 2 is a HPLC chart of PPT saponin before enzymolysis in example 2;
FIG. 3 is a graph of HPLC analysis of the product of the enzymolysis reaction of PPD saponin solution in example 2;
FIG. 4 is a graph of HPLC analysis of the product of the enzymatic hydrolysis of PPT saponin solution of example 2;
FIG. 5 is the molecular structural formula of S-PPD and R-PPD in example 2;
FIG. 6 is the molecular structural formulae of S-PPT and R-PPT in example 2;
FIG. 7 is a diagram showing the mechanism of molecular conversion during the enzymolysis reaction of PPD saponin in example 2;
FIG. 8 is a diagram showing the mechanism of molecular transformation during the enzymolysis reaction of PPT saponin in example 2.
Detailed Description
Example 1A method for preparing ginsenoside glycosidase
Step 1, preparing a basic culture medium
The 1L basal medium consists of the following components: 10g peptone, 5g glucose, 2g ZnCl 2 983g of water.
Mixing the basic culture medium components in proportion to prepare mixed solution; sterilizing at 121deg.C for 20min, and cooling to 25deg.C to obtain basic culture medium.
Step 2, inoculating strains
Inoculating strain into basic culture medium, wherein the strain is Aspergillus oryzae, latin school name: aspergillus oryzae, strain deposit number: CGMCC 3.13904. The inoculation amount is 8%.
Step 3, culturing
After inoculation is completed, culturing is carried out at 28 ℃ under normal pressure, and sterile air is introduced, wherein the introduction amount of the sterile air is 1 m/hour; culturing for 3d.
Step 4, primary induction
After 3d of cultivation, 1g of glycerin and 1g of PPD saponin (diol ginsenoside) were added to the medium, and cultivation was continued for 3d.
The PPD saponin is prepared from ginsenoside Rb1, rb2, rb3, rc and Rd according to the ratio of 0.5:1:0.2:1: mixing at a ratio of 0.5.
Step 5, secondary induction
After 3d of cultivation, 1g of PPT saponin (triol ginsenoside) was added to the medium, and the medium was cultivated for 3d, and sterile water was appropriately added according to the water loss during the cultivation.
The PPT saponin is prepared from ginsenoside R1, re and Rg1 according to the following ratio of 0.2:1: mixing at a ratio of 0.5.
Step 6, extracting
After removing the cells by centrifugation, the liquid phase is retained. To the centrifuged liquid phase was added 3.5L of 95% (volume fraction) edible ethanol. Standing for 3 hr, centrifuging, and collecting precipitate to obtain enzyme protein (a ginsenoside glycosidase).
After detection, a total of 8.3g of enzyme protein was obtained.
Example 2 enzyme protein Performance detection experiments
Step 1, preparing PPD saponin solution
0.4g of PPD saponin (diol ginsenoside) is mixed with 20mL of 0.02M acetic acid-sodium acetate buffer solution with pH of 5.0, and dissolved to obtain PPD saponin solution.
HPLC detection was performed on the PPD saponin solution, and the HPLC profile is shown in FIG. 1.
As can be seen from HPLC, PPD saponin contains Rb1, rb2, rb3, rc, rd.
Wherein Rb1 contains 4 glycosyl groups, two glycosyl groups at carbon number 20 and two glycosyl groups at carbon number 3 respectively; rb2 contains 4 glycosyl groups, one glycosyl group at carbon number 20, one arabinopyranosyl group, and two glycosyl groups at carbon number 3; rb3 contains 4 glycosyl groups, one glycosyl group at carbon number 20, one xylitol group, and two glycosyl groups at carbon number 3; rc contains 4 glycosyl groups, one glycosyl group at carbon number 20, one arabinofuranosyl group, and two glycosyl groups at carbon number 3; rd contains 3 glycosyl groups, one glycosyl group at carbon number 20 and two glycosyl groups at carbon number 3, respectively.
Step 2, preparing PPT saponin solution
0.4g of PPT saponin is mixed with 20mL of 0.02M acetic acid-sodium acetate buffer solution with pH of 5.0, and the mixture is dissolved to obtain PPT saponin solution.
The PPT saponin solution was subjected to HPLC detection and the HPLC profile is shown in figure 2.
As can be seen from HPLC, PPT saponin contains R1, re and Rg1.
Wherein R1 contains 3 glycosyl groups, which are respectively a glycosyl group at the 20 th carbon position and a xylosyl group and a glycosyl group at the 6 th carbon position; re contains 3 glycosyl groups, namely one glycosyl group at the 20 th carbon position and one rhamnosyl group and one glycosyl group at the 6 th carbon position; rg1 contains 2 glycosyl groups, one glycosyl group at carbon number 20 and one glycosyl group at carbon number 6.
Step 3, preparing enzyme solution
8.3g of the enzyme protein prepared in example 1 was dissolved in 500mL of 0.02M acetic acid-sodium acetate buffer pH5.0 to obtain an enzyme solution.
Step 4, reaction
(1) 10mL of the enzyme solution prepared in the step 3 was mixed with 10mL of PPD saponin solution and reacted at 45℃for 48 hours. After the completion of the reaction, 80mL of ethanol was added to the reaction mixture, and the mixture was allowed to stand for 1 hour, centrifuged and the supernatant was collected. The supernatant was checked by HPLC, and the HPLC profile is shown in FIG. 3.
As can be seen from FIG. 3, all of the substrates Rb1, rb2, rb3, rc and Rd are not seen, only the product PPD aglycone, namely the diol ginsenoside is completely converted into aglycone, including S-PPD and R-PPD, and the substrates Rb1, rb2, rb3, rc and Rd are completely converted into aglycone, and the conversion rate is almost 100%. The ginsenoside glycosidase prepared by the invention has no selectivity to the glycosyl position and the glycosyl type of the diol ginsenoside.
In addition, real-time tracking and monitoring are carried out in the reaction process, products obtained in different reaction times are different, and when the reaction is carried out for 2 hours, GYP17, CO, CMC1, CMx and Rd are found in the products by sampling and detecting the reaction liquid; when the reaction is carried out for 5 hours, the reaction liquid is sampled and detected to find that GYP75, CY, CMc, CMx, F2, R-Rg3 and S-Rg3 exist in the product; when the reaction is carried out for 24 hours, sampling and detecting the reaction liquid to find CK, R-Rh2 and S-Rh2 in the products; when the reaction was carried out for 48 hours, the reaction product had only two aglycones of R type and S type.
Based on the tracking and monitoring results and the structure of the saponins, the mechanism of molecular conversion in the enzymolysis reaction of PPD saponins can be inferred as shown in figure 7.
(2) Mixing 10mL of enzyme solution with 10mL of PPT saponin solution, reacting at 45 ℃ for 48h, adding 80mL of ethanol after the reaction is finished, standing for 1h, centrifuging, collecting supernatant, detecting by HPLC, and the HPLC chart is shown in figure 4.
As can be seen from FIG. 4, the substrates R1, re and Rg1 are not seen, only the products PPT aglycone, namely triol ginsenoside, including S-PPT and R-PPT, and the R1, re and Rg1 are completely converted into the aglycone, and the conversion rate is almost 100%. The ginsenoside glycosidase prepared by the invention has no selectivity to the glycosyl position and the glycosyl type of the triol ginsenoside.
In addition, real-time tracking and monitoring are carried out in the reaction process, products obtained in different reaction times are different, and when the reaction is carried out for 5 hours, the reaction liquid is sampled and detected, and Rg1, R-Rg2 and S-Rg2 are found in the products; when the reaction is carried out for 24 hours, the reaction liquid is sampled and detected to find F1, R-Rh1 and S-Rh1 in the products; when the reaction was carried out for 48 hours, only two aglycones of R type and S type were present in the reaction product.
Based on the tracking and monitoring result and the structure of the saponins, the molecular conversion mechanism in the process of the enzymolysis reaction of the PPT saponins can be inferred as shown in figure 8.
As can be seen from the comprehensive figures 3-4, the ginsenoside glycosidase prepared by the invention has no selectivity to ginsenoside aglycone, glycosyl position and glycosyl type, and can hydrolyze diol and triol ginsenoside simultaneously.
The control conditions for HPLC detection described in the present invention are as follows:
the detection wavelength is 203nm. Mobile phase acetonitrile (a) -water (B): 0-20min,20% A,20-31min, 20-32% A,31-40min, 32-43% A,40-47min, 43-100% A. Column temperature was 35 ℃.
Except for specific descriptions, the proportions of the invention are mass ratios, and the percentages are mass percentages.
It is apparent that there are many more specific embodiments that can be varied within the inventive concept, and it should be stated herein that any modification made within the inventive concept of the present invention will fall within the scope of the present invention.
Claims (10)
1. A preparation method of ginsenoside glycosidase is characterized in that: comprises the steps of preparing a basic culture medium, inoculating strains, culturing, primary induction, secondary induction and extraction; the inoculation strain: the strain used is Aspergillus oryzae.
2. The method for preparing ginsenoside glycosidase according to claim 1, wherein: the culture: culturing at 25-30deg.C under normal pressure for 3-4d.
3. The method for preparing ginsenoside glycosidase according to claim 1, wherein: the primary induction: glycerol and PPD saponin are added into the culture medium, and the culture is carried out for 3-4d.
4. A process for preparing ginsenoside glycosidase according to claim 3, wherein: the addition amount of the glycerol is 0.1-0.2% of the mass of the basic culture medium; the adding amount of the PPD saponin is 0.1-1% of the mass of the basic culture medium.
5. A process for preparing ginsenoside glycosidase according to claim 3, wherein: the PPD saponin is prepared from ginsenoside Rb1, rb2, rb3, rc and Rd according to the ratio of (0.2-1): (0.2-1): (0.2-1): (0.2-1) and mixing the components.
6. The method for preparing ginsenoside glycosidase according to claim 1, wherein: the secondary induction: PPT saponin is added into the culture medium, and the culture is carried out for 3-4d.
7. The method for preparing ginsenoside glycosidase according to claim 6, wherein: the addition amount of the PPT saponin is 0.1-1% of the mass of the basic culture medium.
8. The method for preparing ginsenoside glycosidase according to claim 6, wherein: the PPT saponin is prepared from ginsenoside R1, re and Rg1 according to the ratio of (0.2-1): (0.2-1) and mixing the components.
9. The method for preparing ginsenoside glycosidase according to claim 1, wherein: the preparation of the basal culture medium comprises the following steps: comprises the following components in percentage by mass: 0.8-1.2% peptone, 0.1-1% glucose, 0.1-0.3% ZnCl 2 The water makes up the balance.
10. The method for preparing ginsenoside glycosidase according to claim 1, wherein: the prepared ginsenoside glycosidase has no selectivity to ginsenoside aglycone, glycosyl position and glycosyl type, and can hydrolyze diol and triol ginsenoside simultaneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310809585.0A CN117126830A (en) | 2023-07-04 | 2023-07-04 | Preparation method of ginsenoside glycosidase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310809585.0A CN117126830A (en) | 2023-07-04 | 2023-07-04 | Preparation method of ginsenoside glycosidase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117126830A true CN117126830A (en) | 2023-11-28 |
Family
ID=88861791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310809585.0A Pending CN117126830A (en) | 2023-07-04 | 2023-07-04 | Preparation method of ginsenoside glycosidase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117126830A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118773170A (en) * | 2024-08-13 | 2024-10-15 | 北京化工大学 | Application and method of a glycoside hydrolase with dual enzyme activity and its recombinant bacteria in preparing rare ginsenosides |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995030009A2 (en) * | 1994-04-29 | 1995-11-09 | Gatsby Charitable Foundation | Identification, production and use of saponin glyclosyl hydrolases |
| WO2002053722A1 (en) * | 2000-12-29 | 2002-07-11 | Fengxie Jin | Ginsenoside glycosidase which hydrolyzes ginsenoside glycosyl and the use thereof |
| CN103966105A (en) * | 2013-11-28 | 2014-08-06 | 河南科技学院 | A kind of aspergillus oryzae that transforms ginsenoside Rg3 to produce Rh2, production method and application |
| CN104894204A (en) * | 2015-05-27 | 2015-09-09 | 金凤燮 | Method for preparing ginseng rare saponin by virtue of microorganism enzymatic conversion of ginsenosid Re |
| CN107308195A (en) * | 2017-06-30 | 2017-11-03 | 肖永坤 | A kind of method that high activity ginsenoside is prepared by solid dynamic fermentation technology |
-
2023
- 2023-07-04 CN CN202310809585.0A patent/CN117126830A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995030009A2 (en) * | 1994-04-29 | 1995-11-09 | Gatsby Charitable Foundation | Identification, production and use of saponin glyclosyl hydrolases |
| WO2002053722A1 (en) * | 2000-12-29 | 2002-07-11 | Fengxie Jin | Ginsenoside glycosidase which hydrolyzes ginsenoside glycosyl and the use thereof |
| CN103966105A (en) * | 2013-11-28 | 2014-08-06 | 河南科技学院 | A kind of aspergillus oryzae that transforms ginsenoside Rg3 to produce Rh2, production method and application |
| CN104894204A (en) * | 2015-05-27 | 2015-09-09 | 金凤燮 | Method for preparing ginseng rare saponin by virtue of microorganism enzymatic conversion of ginsenosid Re |
| CN107308195A (en) * | 2017-06-30 | 2017-11-03 | 肖永坤 | A kind of method that high activity ginsenoside is prepared by solid dynamic fermentation technology |
Non-Patent Citations (3)
| Title |
|---|
| 崔玉娜;张怡轩;赵余庆;: "利用生物转化法制备稀有人参皂苷的研究进展", 中草药, no. 05, 12 May 2009 (2009-05-12) * |
| 李东霄;常景玲;张志宏;: "微生物转化人参皂苷Rc和Rd的研究", 江苏农业科学, no. 04, 15 August 2010 (2010-08-15) * |
| 雷晶;黄文;李天宏;: "黄姜皂苷水解烟曲霉的分离及其β-糖苷酶性质初探", 北京大学学报(自然科学版), no. 05, 7 June 2011 (2011-06-07) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118773170A (en) * | 2024-08-13 | 2024-10-15 | 北京化工大学 | Application and method of a glycoside hydrolase with dual enzyme activity and its recombinant bacteria in preparing rare ginsenosides |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105648021A (en) | Preparation method for rare ginsenoside C-K and F1 and four kinds of isomer ginsengenin | |
| CN116426391B (en) | Aureobasidium pullulans Aureobasidium pullulans P1 and application thereof | |
| KR20210058416A (en) | Novel Aspergillus tubingensis C2-2 isolated from Nu-ruk producing ginsenoside compound K biotransformation enzyme and use thereof | |
| CN116836818B (en) | Penicillium strain F8816 and application thereof | |
| CN117089465B (en) | Aspergillus wart and application thereof | |
| CN117126830A (en) | Preparation method of ginsenoside glycosidase | |
| CN116426596A (en) | Method for preparing red ginseng Rg3 by biotransformation | |
| CN116098285A (en) | Method for preparing fermentation extract containing rare saponins by utilizing compound microorganism to transform pseudo-ginseng stem and leaf | |
| CN117736884B (en) | Aspergillus ochraceus F8509 and application thereof | |
| CN112575050A (en) | Method for preparing diosgenin by biological conversion | |
| US20250002966A1 (en) | Aureobasidium pullulans p1 and method for preparing rare ginsenoside | |
| CN105671089B (en) | Method for co-producing taxanes and ethanol using Taxus chinensis | |
| KR102244275B1 (en) | Method for Preparation of Bioconverted Red Ginseng with Enhanced compound K content | |
| CN113273643A (en) | Tannin preparation for feed and preparation method thereof | |
| CN103911402B (en) | A kind of method utilizing beet fermenting lactic acid | |
| CN113717860B (en) | Application of Huang Lanzhuang bacteria in conversion of total saponins of Notoginseng radix into small-polarity ginsenoside | |
| CN101012473B (en) | Penicillium sclerotiorum or Mycobacterium verrucosus and method for preparing ginsenoside F1 using it | |
| CN119979651A (en) | A method for preparing rare saponin and rare saponin | |
| CN109609581A (en) | A kind of microbial mixed fermentation transformation and degradation of astragaloside IV to prepare cycloastragalus alcohol | |
| KR101959848B1 (en) | Method of producing rare ginseng saponin by using Formitella fracinea mycelia | |
| CN103044511A (en) | Technology for separating ergosterone from Phellinus | |
| KR20230087305A (en) | Method for Preparation of Bioconverted Red Ginseng with Enhanced Ginsenoside F1 and Compound K Content | |
| CN111118096A (en) | Enzymatic preparation method of saponin | |
| CN109022530B (en) | Preparation method of ginsenoside Ro | |
| CN115786133B (en) | Aspergillus thermal strain CLH-22, application thereof, starter and method for preparing 3-oxo-glycyrrhetinic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |